KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Change in Inventory (2018 - 2025)

Historic Change in Inventory for Takeda Pharmaceutical (TAK) over the last 8 years, with Q4 2025 value amounting to -$246.6 million.

  • Takeda Pharmaceutical's Change in Inventory fell 27655.43% to -$246.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$566.2 million, marking a year-over-year decrease of 39306.22%. This contributed to the annual value of -$229.6 million for FY2025, which is 7139.31% up from last year.
  • Per Takeda Pharmaceutical's latest filing, its Change in Inventory stood at -$246.6 million for Q4 2025, which was down 27655.43% from -$196.6 million recorded in Q3 2025.
  • Takeda Pharmaceutical's 5-year Change in Inventory high stood at $188.2 million for Q1 2021, and its period low was -$342.0 million during Q4 2023.
  • For the 5-year period, Takeda Pharmaceutical's Change in Inventory averaged around -$119.4 million, with its median value being -$108.1 million (2021).
  • In the last 5 years, Takeda Pharmaceutical's Change in Inventory plummeted by 60862.58% in 2023 and then skyrocketed by 14084.61% in 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Change in Inventory (Quarter) stood at -$125.8 million in 2021, then dropped by 3.86% to -$130.7 million in 2022, then crashed by 161.71% to -$342.0 million in 2023, then skyrocketed by 140.85% to $139.7 million in 2024, then tumbled by 276.55% to -$246.6 million in 2025.
  • Its Change in Inventory was -$246.6 million in Q4 2025, compared to -$196.6 million in Q3 2025 and -$90.3 million in Q2 2025.